Can ERCP contrast agents cause pseudomicrolithiasis? Their effect on the final outcome of bile analysis in patients with suspected microlithiasis

Background: Microlithiasis has been implicated in the etiology of idiopathic pancreatitis and biliary-type pain in patients with intact gallbladders. Contrast injection at endoscopic retrograde cholangiopancreatography (ERCP) is used to confirm access into the bile duct and bile is also aspirated to...

Full description

Saved in:
Bibliographic Details
Published in:Gastrointestinal endoscopy 2000-04, Vol.51 (4), p.401-404
Main Authors: Parasher, Vinod K., Romain, Kathleen, Sukumar, Raman, Jordan, John
Format: Article
Language:English
Subjects:
Bile - chemistry
Biological and medical sciences
Cholangiopancreatography, Endoscopic Retrograde - adverse effects
Cholelithiasis - etiology
Cholelithiasis - pathology
Contrast Media - adverse effects
Contrast Media - chemistry
Diagnosis, Differential
Female
Humans
Iohexol - adverse effects
Iohexol - chemistry
Male
Medical sciences
Miscellaneous
Pharmacology. Drug treatments
Photomicrography
Risk Assessment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Microlithiasis has been implicated in the etiology of idiopathic pancreatitis and biliary-type pain in patients with intact gallbladders. Contrast injection at endoscopic retrograde cholangiopancreatography (ERCP) is used to confirm access into the bile duct and bile is also aspirated to look for microlithiasis. It is not known whether contrast agents contain crystals that could mimic true microlithiasis. Methods: Four mL of 2 contrast agents (Hypaque and Omnipaque) were examined after centrifugation under polarizing microscopy. In the second part of the study, bile aspirated during ERCP with contrast injection was examined for microlithiasis and contrast pseudomicrolithiasis. Results: Contrast agents exhibited pseudomicrolithiasis that mimicked calcium bilirubinate granules. Pathologists participating in the study were not aware of contrast pseudomicrolithiasis. Nine of twelve (75%) patients would have been reported as having microlithiasis and would possibly have undergone an unnecessary cholecystectomy. Conclusion: When bile collected during ERCP is to be examined for microlithiasis, it should be collected without contamination by a contrast agent. If this is not possible, pathologists should be aware that contrast can cause pseudomicrolithiasis. (Gastrointest Endosc 2000;51:401-4.)
ISSN:0016-5107
1097-6779
DOI:10.1016/S0016-5107(00)70438-X